Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of a Vaccine against Human Cytomegalovirus: Advances, Barriers, and Implications for the Clinical Practice
Sara Scarpini, Francesca Morigi, Ludovica Betti, et al.
Vaccines (2021) Vol. 9, Iss. 6, pp. 551-551
Open Access | Times Cited: 63

Showing 26-50 of 63 citing articles:

Structure-based design of a soluble human cytomegalovirus glycoprotein B antigen stabilized in a prefusion-like conformation
Madeline R. Sponholtz, Patrick O. Byrne, Alison G. Lee, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Cytomegalovirus Corneal Endotheliitis: A Comprehensive Review
Woong-Sun Yoo, Lee-Ha Kwon, Youngsub Eom, et al.
Ocular Immunology and Inflammation (2024) Vol. 32, Iss. 9, pp. 2228-2237
Closed Access | Times Cited: 3
Polyploid Giant Cancer Cells: A Distinctive Feature in the Transformation of Epithelial Cells by High-Risk Oncogenic HCMV Strains
Georges Herbein, Ranim El Baba
Viruses (2024) Vol. 16, Iss. 8, pp. 1225-1225
Open Access | Times Cited: 3
Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells
Junping Hong, Dongmei Wei, L. Zhong, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
The effects of cytomegalovirus on brain structure following sport-related concussion
Jonathan Savitz, Bryna D. Goeckner, Bart N. Ford, et al.
Brain (2023) Vol. 146, Iss. 10, pp. 4262-4273
Open Access | Times Cited: 9
Current Perspectives on the Management of Herpesvirus Infections in Solid Organ Transplant Recipients
S. Reshwan K. Malahe, Jeroen J. A. van Kampen, Olivier C. Manintveld, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1595-1595
Open Access | Times Cited: 8
Indirect effects of cytomegalovirus infection: Implications for vaccine development
P.T. Moseley, Paul Klenerman, Seilesh Kadambari
Reviews in Medical Virology (2022) Vol. 33, Iss. 1
Open Access | Times Cited: 12
Challenges, Recent Advances and Perspectives in the Treatment of Human Cytomegalovirus Infections
Shiu‐Jau Chen, Shao-Cheng Wang, Yuan‐Chuan Chen
Tropical Medicine and Infectious Disease (2022) Vol. 7, Iss. 12, pp. 439-439
Open Access | Times Cited: 10
Employing carbon quantum dots to combat cytomegalovirus
Tanja Bulat, Danica Zmejkoski, Zoran Marković, et al.
Materials Chemistry and Physics (2023) Vol. 311, pp. 128495-128495
Open Access | Times Cited: 6
Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
Sanying Wang, Xuqiang Zhou, Xinyue He, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 9
Meeting vaccine formulation challenges in an emergency setting: Towards the development of accessible vaccines
Allegra Peletta, Céline Lemoine, Thomas Courant, et al.
Pharmacological Research (2023) Vol. 189, pp. 106699-106699
Open Access | Times Cited: 5
CCR4‐NOT differentially controls host versus virus poly(a)‐tail length and regulates HCMV infection
Hannah M. Burgess, Rebecca Grande, Sofia Riccio, et al.
EMBO Reports (2023) Vol. 24, Iss. 12
Open Access | Times Cited: 4
Structure-Guided Mutagenesis Targeting Interactions between pp150 Tegument Protein and Small Capsid Protein Identify Five Lethal and Two Live-Attenuated HCMV Mutants
Alexander Stevens, Ruth Cruz‐Cosme, Najealicka Armstrong, et al.
Virology (2024) Vol. 596, pp. 110115-110115
Open Access | Times Cited: 1
Human cytomegalovirus microRNAs: strategies for immune evasion and viral latency
Mohammad Sabbaghian, Hamidreza Gheitasi, Manouchehr Fadaee, et al.
Archives of Virology (2024) Vol. 169, Iss. 8
Closed Access | Times Cited: 1
The association between cytomegalovirus infection and neurodegenerative diseases: a prospective cohort using UK Biobank data
Xuning Ma, Zijun Liao, Henghui Tan, et al.
EClinicalMedicine (2024) Vol. 74, pp. 102757-102757
Open Access | Times Cited: 1
Transplacental Antibodies
Alexandra K Medoro, Karen M. Puopolo
Clinics in Perinatology (2024) Vol. 52, Iss. 1, pp. 101-113
Closed Access | Times Cited: 1
Sulphated glucuronomannan tetramer and hexamer from Sargassum thunbergii exhibit anti-human cytomegalovirus activity by blocking viral entry
Sanying Wang, Xiaogang Xu, Chuan Sun, et al.
Carbohydrate Polymers (2021) Vol. 273, pp. 118510-118510
Closed Access | Times Cited: 10
Pre-existing maternal IgG antibodies as a protective factor against congenital cytomegalovirus infection: A mother-child prospective cohort study
Yue Huang, Jiabao Tang, Han Wang, et al.
EBioMedicine (2022) Vol. 77, pp. 103885-103885
Open Access | Times Cited: 7
Future prospects in mRNA vaccine development
Londiwe Simphiwe Mbatha, Jude Akinyelu, Fiona Maiyo, et al.
Biomedical Materials (2023) Vol. 18, Iss. 5, pp. 052006-052006
Closed Access | Times Cited: 3
Identification of novel canonical and cryptic HCMV-specific T-cell epitopes for HLA-A∗03 and HLA-B∗15 via peptide-PRISM
Alice Felicitas Rein, Chris D. Lauruschkat, Ihsan Muchsin, et al.
Blood Advances (2023) Vol. 8, Iss. 3, pp. 712-724
Open Access | Times Cited: 3
Cytomegalovirus Pneumonia in Inflammatory Bowel Disease: Literature Review and Clinical Recommendations
Keyu Ren, Chunming Yong, Yanting Wang, et al.
Infection and Drug Resistance (2023) Vol. Volume 16, pp. 6195-6208
Open Access | Times Cited: 2
In vitro activity of novel 4-iminohydantoin sulfamide derivatives against human cytomegalovirus
Victor Zhirnov, Oleh Shablykin, С. А. Чумаченко, et al.
Chemical Papers (2023) Vol. 78, Iss. 1, pp. 133-140
Closed Access | Times Cited: 2
The Current Challenges in Developing Biological and Clinical Predictors of Congenital Cytomegalovirus Infection
Kenji Tanimura, Akiko Uchida, Hitomi Imafuku, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13487-13487
Open Access | Times Cited: 5
Advances in Vaccine Development
Ralph A. Tripp
Vaccines (2021) Vol. 9, Iss. 9, pp. 1036-1036
Open Access | Times Cited: 4
Neuentwicklungen und Ausblick
Doris Oberle
Elsevier eBooks (2024), pp. 141-146
Closed Access

Scroll to top